Outer membrane protein of
View Patent ↗Diagnostic tools for serodiagnosing ehrlichiosis in mammals, particularly in members of the Canidae family and in humans are provided. The diagnostic tools are a group of outer membrane proteins of E. chaffeensis and variants thereof, referred to hereinafter as the “OMP proteins”, a group of outer membrane proteins of E. canis and variants thereof referred to hereinafter as the “P30F proteins”, and antibodies to the ONP proteins and the P30F proteins. The OMP proteins of E. chaffeensis encompass OMP-1, OMP-1A, OMP1-B, OMP-1C, OMP1-D, OMP1-E, OMP1-F, OMP1-H, OMP-1R, OMP-1S, OMP-1T, OMP-1U, OMP-1V, OMP-1W, OMP-1X, OMP-1Y and OMP-1Z. The P30F proteins of E. canis encompass P30, P30 a , P30-1, P30-2, P30-3; P30-4, P30-5, P30-6, P30-7, P30-8, P30-9, P30-10, P30-11, and P30-12. Isolated polynucleotides that encode the E. chaffeensis OMP proteins and isolated polynucleotides that encode the E. canis P30F protein are also provided. The present invention also relates to kits containing reagents for diagnosing human ehrlichiosis and canine ehrlichiosis, and to immunogenic compositions containing one or more OMP proteins or P30F proteins.
1. An isolated polynucleotide encoding an outer membrane protein of E. canis , wherein the outer membrane protein is selected from the group consisting of: P30a protein; P30-1 protein; P30-2 protein; P30-3 protein; P30-4 protein; P30-5 protein; P30-6 protein; P30-7 protein; P30-8 protein; P30-9 protein; P30-10 protein; P30-11 protein; and P30-12 protein.
2. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30a protein.
3. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-1 protein.
4. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-2 protein.
5. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-3 protein.
6. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-4 protein.
7. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-5 protein.
8. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-6 protein.
9. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-7 protein.
10. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-8 protein.
11. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-9 protein.
12. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-10 protein.
13. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-11 protein.
14. The isolated polynucleotide of claim 1 , wherein said outer membrane protein of E. canis is the P30-12 protein.
15. The isolated polynucleotide of claim 1 , wherein said polynucleotide comprises a nucleotide sequence selected from the group consisting of: SEQ ID NO: 33, shown in FIG. 20A ; SEQ ID NO: 35, shown in FIG. 21A ; SEQ ID NO: 37, shown in FIG. 22A ; SEQ ID NO: 39, shown in FIG. 23A ; SEQ ID NO: 41, shown in FIG. 24A ; SEQ ID NO: 43, shown in FIG. 25A ; SEQ ID NO: 53, shown in FIG. 26A ; SEQ ID NO: 55, shown in FIG. 27A ; SEQ ID NO: 45, shown in FIG. 28A ; SEQ ID NO: 57, shown in FIG. 29A ; SEQ ID NO: 47, shown in FIG. 30A ; SEQ ID NO: 59, shown in FIG. 31A ; and SEQ ID NO: 61, shown in FIG. 32A .
16. An isolated polynucleotide encoding a variant of an outer membrane protein of E. canis,
wherein said variant has at least 95% identity to an amino acid sequence selected from the group consisting of: amino acid 26 through 287 of P30a (SEQ ID NO: 34), shown in FIG. 20B ; amino acid 55 through 307 of P30-1 (SEQ ID NO: 36), shown in FIG. 21B ; amino acid 26 through 280 of P30-2 (SEQ ID NO: 38), shown in FIG. 22B ; amino acid 26 through 283 of P30-3 (SEQ ID NO: 40), shown in FIG. 23B ; amino acid 26 through 276 of P30-4 (SEQ ID NO: 42), shown in FIG. 24B ; amino acid 27 through 293 of P30-5 (SEQ ID NO: 44), shown in FIG. 25B ; amino acid 31 through 293 of P30-6 (SEQ ID NO: 54), shown in FIG. 26B ; amino acid 31 through 296 of P30-7 (SEQ ID NO: 56), shown in FIG. 27B ; amino acid 27 through 299 of P30-8 (SEQ ID NO: 46), shown in FIG. 28B ; amino acid 27 through 281 of P30-9 (SEQ ID NO: 58), shown in FIG. 29B ; amino acid 26 through 280 of P30-10 (SEQ ID NO: 48), shown in FIG. 30B ; amino acid 26 through 279 of P30-11 (SEQ ID NO: 60), shown in FIG. 31B ; and amino acid 1 through 241 of P30-12 (SEQ ID NO: 62), shown in FIG. 32B , and
wherein said variant is immunoreactive with at least one antibody that binds to said P30a, P30-1, P30-2, P30-3, P30-4, P30-5, P30-6, P30-7, P30-8, P30-9, P30-10, P30-11, or P30-12 protein, respectively.
17. A vector for transformation of a host cell, said vector comprising an isolated polynucleotide that encodes an outer membrane protein of E. canis , a variant of said outer membrane protein, or an immunogenic fragment of said outer membrane protein,
wherein said outer membrane protein is selected from the group consisting of: P30a protein; P30-1 protein; P30-2 protein; P30-3 protein; P30-4 protein; P30-5 protein; P30-6 protein; P30-7 protein; P30-8 protein; P30-9 protein; P30-10 protein; P30-11 protein; and P30-12 protein.
18. The vector of claim 17 , wherein said vector is used in a process for making the corresponding outer membrane protein of E. canis , a variant of said outer membrane protein, or an immunogenic fragment of said outer membrane protein, said process comprising transfecting host cells with said vector and inducing expression of the outer membrane protein or the variant or immunogenic fragment thereof in the host cells.